Document Detail

Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats.
MedLine Citation:
PMID:  15371279     Owner:  NLM     Status:  MEDLINE    
A nonselective inhibitor of cyclooxygenase (COX; high-dose aspirin) and a relatively selective inhibitor of inducible nitric oxide synthase (iNOS; aminoguanidine) have been found to inhibit development of diabetic retinopathy in animals, raising a possibility that NOS and COX play important roles in the development of retinopathy. In this study, the effects of hyperglycemia on retinal nitric oxide (NO) production and the COX-2 pathway, and the interrelationship of the NOS and COX-2 pathways in retina and retinal cells, were investigated using a general inhibitor of NOS [N(G)-nitro-l-arginine methyl ester (l-NAME)], specific inhibitors of iNOS [l-N(6)-(1-iminoethyl)lysine (l-NIL)] and COX-2 (NS-398), and aspirin and aminoguanidine. In vitro studies used a transformed retinal Müller (glial) cell line (rMC-1) and primary bovine retinal endothelial cells (BREC) incubated in 5 and 25 mM glucose with and without these inhibitors, and in vivo studies utilized retinas from experimentally diabetic rats (2 mo) treated or without aminoguanidine or aspirin. Retinal rMC-1 cells cultured in high glucose increased production of NO and prostaglandin E(2) (PGE(2)) and expression of iNOS and COX-2. Inhibition of NO production with l-NAME or l-NIL inhibited all of these abnormalities, as did aminoguanidine and aspirin. In contrast, inhibition of COX-2 with NS-398 blocked PGE(2) production but had no effect on NO or iNOS. In BREC, elevated glucose increased NO and PGE(2) significantly, whereas expression of iNOS and COX-2 was unchanged. Viability of rMC-1 cells or BREC in 25 mM glucose was significantly less than at 5 mM glucose, and this cell death was inhibited by l-NAME or NS-398 in both cell types and also by l-NIL in rMC-1 cells. Retinal homogenates from diabetic animals produced significantly greater than normal amounts of NO and PGE(2) and of iNOS and COX-2. Oral aminoguanidine and aspirin significantly inhibited all of these increases. The in vitro results suggest that the hyperglycemia-induced increase in NO in retinal Müller cells and endothelial cells increases production of cytotoxic prostaglandins via COX-2. iNOS seems to account for the increased production of NO in Müller cells but not in endothelial cells. We postulate that NOS and COX-2 act together to contribute to retinal cell death in diabetes and to the development of diabetic retinopathy and that inhibition of retinopathy by aminoguanidine or aspirin is due at least in part to inhibition of this NO/COX-2 axis.
Yunpeng Du; V P Sarthy; T S Kern
Related Documents :
8745299 - The role of prostaglandins in blastocyst implantation.
22114909 - Excessive dpp signaling induces cardial apoptosis through dtak1 and djnk during late em...
21912729 - Toll-like receptors are potential therapeutic targets in rheumatoid arthritis.
21562469 - Apoptosis and acute kidney injury.
21884179 - Mitoxosome: a mitochondrial platform for cross-talk between cellular stress and antivir...
20599489 - Using (18)f-fdg micropet imaging to measure the inhibitory effects of clematis chinensi...
21114459 - Th17-cytokine blockers as a new approach for treating inflammatory bowel disease.
3280179 - Immunohistochemical demonstration of migration inhibitory factor (mif) in experimental ...
9862689 - Differential effects of cd28 engagement and il-12 on t cell activation by altered pepti...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  American journal of physiology. Regulatory, integrative and comparative physiology     Volume:  287     ISSN:  0363-6119     ISO Abbreviation:  Am. J. Physiol. Regul. Integr. Comp. Physiol.     Publication Date:  2004 Oct 
Date Detail:
Created Date:  2004-09-16     Completed Date:  2004-10-20     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  100901230     Medline TA:  Am J Physiol Regul Integr Comp Physiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  R735-41     Citation Subset:  IM    
Clinical and Molecular Endocrinology, Dept. of Medicine, 434 Biomedical Research Bldg., Case Western Reserve Univ., 10900 Euclid Ave., Cleveland, OH 44106-4951, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aspirin / pharmacology
Blotting, Western
Cell Death / drug effects,  physiology
Cells, Cultured
Cyclooxygenase 2
Diabetes Mellitus, Experimental / enzymology,  pathology*
Diabetic Retinopathy / enzymology,  pathology*
Dinoprostone / metabolism
Endothelial Cells / drug effects,  metabolism
Glucose / pharmacology*
Guanidines / pharmacology
Isoenzymes / metabolism
Nitric Oxide / physiology*
Nitric Oxide Synthase / metabolism
Nitric Oxide Synthase Type II
Prostaglandin-Endoperoxide Synthases / metabolism,  physiology*
Prostaglandins / metabolism
Rats, Sprague-Dawley
Retina / cytology,  pathology*
Grant Support
Reg. No./Substance:
0/Guanidines; 0/Isoenzymes; 0/Prostaglandins; 10102-43-9/Nitric Oxide; 363-24-6/Dinoprostone; 50-78-2/Aspirin; 50-99-7/Glucose; 79-17-4/pimagedine; EC Oxide Synthase; EC Oxide Synthase Type II; EC protein, rat; EC 2; EC Synthases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Depressor and bradycardic responses to microinjections of endomorphin-2 into the NTS are mediated vi...
Next Document:  Effects of protein malnutrition on IL-6-mediated signaling in the liver and the systemic acute-phase...